Impact of s acubitril/valsartan on chronic heart failure patients with sleep-disordered breathing: a systematic review and meta-analysis
Abstract Chronic heart failure (CHF) affects 1–2% of adults in developed countries, with up to 50% experiencing sleep-disordered breathing (SDB). Sacubitril/valsartan (sac/val) has shown potential benefits on respiratory function, but its effect on SDB remains uncertain. This study aims to evaluates...
Saved in:
| Main Authors: | Xuyuan Kuang, Chunyan Ye, Yongqiu Xie, E. Wang, Na Chen, Chuyan Yang, Siting Zhong, Lu Liao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-14458-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expert Opinion on the Role of Sacubitril/Valsartan in the Management of Hypertension in India
by: Uday M. Jadhav, et al.
Published: (2024-11-01) -
Effects of sacubitril valsartan on renal function and renal safety in patients with heart failure: a Meta-analysis
by: Ma Zhou, et al.
Published: (2022-09-01) -
The Effect of Sacubitril/Valsartan on Supraventricular and Ventricular Arrhythmias in Patients With Heart Failure
by: Alireza Arzhangzadeh, et al.
Published: (2025-05-01) -
The use of sacubitril/valsartan in different forms of heart failure
by: Mohammad Abumayyaleh, et al.
Published: (2025-06-01) -
Effectiveness of Sacubitril/Valsartan in Preventing Heart Failure in STEMI Post-Percutaneous Coronary Intervention
by: Nobian Andre, et al.
Published: (2023-12-01)